✦ LIBER ✦

PD-154 An open-label, multi centre phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)

✍ Scribed by Reck, M.; Buchholz, E.; Gahlemann, C.; Gatzemeier, U.; Manegold, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-489 An open label, multicenter, non-co

✍ Grunberg, S.; Clarkson, J.; Harper, H.; Gomolin, H.; Guthrie, T.; Bandekar, R.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

PD-070 SIGN: A Phase II, open-label, ran

✍ Cufer, T.; Vrdoljak, E. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

O-089 ERCC1 mRNA-based randomized phase

✍ Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A randomized phase II trial of sequentia

✍ Grigorescu, Alexandru; Ciuleanu, Tudor; Firoiu, Elena; Muresan, Delia Ruta; Teod 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 249 KB

P382 A randomized phase II trial of sequ

✍ Teodorescu, G.; Ciuleanu, T.; Grigorescu, A.; Firoiu, E.; Ruta Muresan, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

PD-039 A phase II study of cetuximab (C2

✍ Blumenschein, G.; Swann, S.; Curran, W.; Robert, F.; Werner Wasik, M.; Jafar, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB